SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-006868
Filing Date
2021-03-24
Accepted
2021-03-24 16:45:03
Documents
1
Period of Report
2021-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3995
  Complete submission text file 0001567619-21-006868.txt   5525
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3300 LOWELL STREET NW WASHINGTON DC 20008
Business Address
Birx Deborah (Reporting) CIK: 0001849673 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 21768704